Wendy Stevens to Cost-Benefit Analysis
This is a "connection" page, showing publications Wendy Stevens has written about Cost-Benefit Analysis.
Connection Strength
0,330
-
Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and SARS-CoV-2. BMJ Glob Health. 2024 Dec 03; 9(12).
Score: 0,211
-
Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension. J Am Heart Assoc. 2021 04 06; 10(7):e015816.
Score: 0,041
-
Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale. Health Econ. 2016 Feb; 25 Suppl 1:53-66.
Score: 0,028
-
Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature. 2015 Dec 03; 528(7580):S68-76.
Score: 0,028
-
Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis. AIDS. 2012 Aug 24; 26(13):1663-72.
Score: 0,022